Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
varicella virus vaccine live
- Development stage
- Approved
- Lead developer
- Merck
- Modality
- DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Prophylactic Vaccines → Vaccines & Immunotherapeutics, Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Subcutaneous
01
Overview
Varicella virus vaccine live is a biologic vaccine containing the live, attenuated Oka/Merck strain of the varicella-zoster virus (VZV), developed to induce active immunity against chickenpox (varicella). The mechanism of action involves stimulating the immune system to produce antibodies and cell-mediated responses that protect against VZV infection. It is primarily indicated for immunization in individuals 12 months of age and older who have not had chickenpox, with two doses recommended for full protection. The vaccine is available as a monovalent formulation (Varivax) and as part of combination vaccines in some regions. It significantly reduces both incidence and severity of chickenpox[1][2][3][5][8].
- Brand names
- VarivaxVarilrix
- Other names
- Oka/Merck strain varicella vaccine live attenuatedvaricella vaccine
Beyond the preview
Go deeper on varicella virus vaccine live.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on varicella virus vaccine live.